Way Forward
startup series
Dr Sarkar discovered a novel method of detection in the year 2011 . He tried it on suspected TB patients , and encouraged , by the preliminary results , decided to setup Annweshan SciTech to bring affordable TB diagnosis to the common people .
Over the past two years , Annweshan has generated data on approximately 1800 + samples , going beyond what was required for their BIG project .
dispute resolution . However , their expectations remain high , and they look forward to more support from the incubator to help them get stabilized and develop the product on time .
Asked to comment on their experience with BIRAC , Manikankana mentions , “ While our initial funding support has come from BIRAC , we found the lack of follow-on funding from BIRAC a bit intriguing !” Given , the potential market of a reliable and affordable TB diagnostic in India , the founders now look forward to follow-on funding from other DBT and DST grants along with investor funding , all of which have been elusive uptil now .
Way Forward
The TB diagnostic market size in Brazil , China , India , South Africa was worth approximately $ 480 million in 2013 , which is 46 % of the global market ($ 1.03bn ). The founders say that India ’ s market size for the product is 25 % of global requirements . Their revenue expectation by the 4th year ( 2021 ) of marketing is approximately INR 80 crore and INR 149 crore for India and globally respectively .
40 BioVoiceNews | September 2017